Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immuron Limited (DE:ANW)
FRANKFURT:ANW
Holding DE:ANW?
Track your performance easily
ANW Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.03 - €0.11
Previous CloseN/A
Volume0.00
Average Volume (3M)1.05K
Market Cap
€12.05M
Enterprise ValueN/A
Total Cash (Recent Filing)$3.99M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.13
Next Earnings
Feb 26, 2025Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding233,526,870
10 Day Avg. Volume3,158
30 Day Avg. Volume1,053
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)16.10
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-6.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Immuron Limited News
PremiumCompany Announcements
Immuron Limited Issues New Ordinary Shares Complying with Legal Standards
PremiumCompany Announcements
Immuron Limited Applies for Quotation of New SecuritiesPremiumCompany Announcements
Immuron Limited Reports Strong Travelan® Sales Growth in December 2024
PremiumCompany Announcements
Immuron Limited Announces Proposed Issue of Securities
PremiumCompany Announcements
Immuron Partners with Monash University to Combat Antimicrobial ResistanceOptions Prices
Currently, No data available
---
Ownership Overview
ANW FAQ
What was Immuron Limited’s price range in the past 12 months?
Immuron Limited lowest stock price was €0.03 and its highest was €0.11 in the past 12 months.
What is Immuron Limited’s market cap?
Immuron Limited’s market cap is €12.05M.
When is Immuron Limited’s upcoming earnings report date?
Immuron Limited’s upcoming earnings report date is Feb 26, 2025 which is in 38 days.
How were Immuron Limited’s earnings last quarter?
Currently, no data Available
Is Immuron Limited overvalued?
According to Wall Street analysts Immuron Limited’s price is currently Overvalued.
Does Immuron Limited pay dividends?
Immuron Limited does not currently pay dividends.
What is Immuron Limited’s EPS estimate?
Immuron Limited’s EPS estimate is 0.
How many shares outstanding does Immuron Limited have?
Immuron Limited has 233,526,870 shares outstanding.
What happened to Immuron Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Immuron Limited?
Currently, no hedge funds are holding shares in DE:ANW
---
Immuron Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
DE:ANW Sentiment 94%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
2.38%
12-Months-Change
Fundamentals
Return on Equity
-42.36%
Trailing 12-Months
Asset Growth
-27.77%
Trailing 12-Months
Company Description
Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
---
Technical Analysis
---